Getz Pharma (Private) Limited | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,626 results for “Getz Pharma (Private) Limited”

CCP Approves Getz Group's Acquisition of Novartis Pakistan in Major Pharmaceutical Transaction

Biotech Industry Adapts to Evolving Challenges: AI and Innovation Key to Clinical Trial Success

Aurobindo Pharma's Apitoria to Acquire 80% Stake in A1 Biochem CRO for $17 Million, Building Integrated CRDMO Platform

MAIA Biotechnology Secures $2.44 Million to Advance THIO-101 Trial in NSCLC

Pharmaceutical Industry Faces Widespread Layoffs Amid Patent Cliffs and Economic Uncertainty

Theralase Closes Private Placement to Advance Bladder Cancer Clinical Study

MAIA Biotechnology Secures $2.44 Million to Advance THIO-101 Trial in NSCLC

Nigerian Army Pursues Public-Private Partnerships to Modernise Military Healthcare Facilities

MAIA Biotechnology Secures $2.44 Million to Advance THIO-101 Trial in NSCLC

Swiss Biotech Sector Achieves Record Revenue and 38% Private Funding Surge in 2025

Page 1 of 1243